Delivery Order SPE2DB22D9353-SPE2DB25FX2AR
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $29.8K on July 21, 2025, for the supply of Vabysmo 6 mg/0.05 mL syringes. This firm fixed-price delivery order is set to be completed by August 11, 2025, and represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program. The parent contract,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,966.88 to DMS Pharmaceutical Group Inc. for VABYSMO 6 mg/0.05 ml syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a direct procurement of pharmaceutical supplies to support military healthcare operations. VABYSMO is a prescription ophthalmic medication used in treating age-related macular degeneration, and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,224.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, with a period of performance through April 2, 2024. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB, valued up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, with a ceiling value of $8,950.32 and a period of performance through June 6, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,224.44 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of Vabysmo 6 mg/0.05 ml syringes, with a ceiling value of $6,224.44 and a period of performance through February 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the issuance of firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,341.65 firm fixed-price delivery order is for the supply of a specialized ophthalmic medication, VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML, with a period of performance through December 23, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a $6,224.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, with a period of performance through November 7, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $48,013.50, is for the delivery of VABYSMO 6 MG/0.05 ML VIAL 0.05ML, a prescription pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to DMS Pharmaceutical Group by the DLA under the SPE2DB program, which has a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,983.44, is for the delivery of VABYSMO 6 MG/0.05 ML SYRINGE 0.05ML medical supplies. The contract has an ultimate completion date of May 1, 2025 and was awarded on April 10, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2ARDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for the supply of Vabysmo 6 mg/0.05 mL syringes valued at $4,475.16. The award, issued on July 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order does not utilize a set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the DLA supporting Department of Defense healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. Vabysmo, an ophthalmic medication used in treating retinal conditions, represents one of many specialized pharmaceutical products the company supplies to military health facilities nationwide, reinforcing DMS Pharmaceutical Group's critical role in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 7/31/25 |